InsidersTradesSigma
Follow the RACURA ONCOLOGY LTD stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the supervision of ASX. Market capitalisation: €411.7m. The latest transaction was filed on 28 May 2026 (Mixed). Among the most active insiders: Daniel Tillett. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Racura Oncology Ltd is a company focused on developing innovative cancer treatments. It is listed on the XASX market.